O'Shaughnessy Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

O'Shaughnessy Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,525	Closed	-$125K	–	2925
2021 Q2	$125K	Hold	4,525	–	–	﹤0.01%	1223
2021 Q1	$75K	Sell	4,525 -4,592	-50%	-$105K	﹤0.01%	1297
2020 Q4	$168K	Buy	+9,117	New	+$163K	﹤0.01%	892

O'Shaughnessy Asset Management's TBIO Position: Q3 2021 in Review

O'Shaughnessy Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 4,525 shares — an estimated $125K sold.

O'Shaughnessy Asset Management first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $168K in Q4 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

O'Shaughnessy Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 4,525 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $125K.
O'Shaughnessy Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
O'Shaughnessy Asset Management's Translate Bio, Inc. Common Stock position peaked at $168K in Q4 2020.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.